Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea

被引:0
|
作者
Wolf, JE [1 ]
Kerrouche, N
Arsonnaud, S
机构
[1] Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA
[2] Galderma Labs LP, Sophia Antipolis, France
来源
CUTIS | 2006年 / 77卷 / 04期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Rosacea is an inflammatory dermatologic disorder characterized by the presence of facial erythema, visible blood vessels, papules, and pustules. The National Rosacea Society has established a classification system that identifies 4 distinct rosacea subtypes based on clinical presentation: erythematotelangiectatic, papulopustular, phymatous, and ocular. The goal of topical therapy for rosacea is to reduce inflammatory lesion counts; decrease intensity of erythema; and reduce symptoms such as stinging, burning, and pruritus. Metronidazole and azelaic acid are thought to reduce the inflammation associated with rosacea by inhibiting the production of reactive oxygen species produced by neutrophils. Both metronidazole 1% gel and azelaic acid 15% gel recently have been approved for the treatment of rosacea. The current study was conducted to compare the once-daily application of metronidazole 1% gel with twice-daily applications of azelaic acid 15% gel for the treatment of patients with moderate rosacea (N=160). Both treatments showed similar reductions in inflammatory lesion counts (77% for metronidazole 1% gel and 80% for azelaic acid 15% gel) and high success rates in both global severity (53.7% vs 56.4% for metronidazole 1% gel and azelaic acid 15% gel, respectively) and erythema (42.7% vs 42.3% for metronidazole 1% gel and azelaic acid 15% gel, respectively). On average, the efficacy (including reduction in erythema) of the once-daily application of metronidazole 1% gel and twice-daily applications of azelaic acid 15% gel were similar.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 50 条
  • [1] Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea
    Thiboutot, Diane M.
    Fleischer, Alan B., Jr.
    Del Rosso, James Q.
    Graupe, Klaus
    JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (06) : 541 - 546
  • [2] Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis
    Livengood, CH
    Soper, DE
    Sheehan, KL
    Fenner, DE
    Martens, MG
    Nelson, AL
    Ismail, M
    Thorp, JM
    Lappin, M
    Long, BJ
    Blackwelder, T
    Sweet, RL
    Sagov, S
    SEXUALLY TRANSMITTED DISEASES, 1999, 26 (03) : 137 - 142
  • [3] Efficacy and safety of metronidazole gel 1% compared to azelaic acid 15% in the treatment of rosacea: A phase IIIB study
    Wolf, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB66 - AB66
  • [4] Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis
    Lebwohl, M
    Ast, E
    Callen, JP
    Cullen, SI
    Hong, SR
    Kulp-Shorten, CL
    Lowe, NJ
    Phillips, TJ
    Rosen, T
    Wolf, DI
    Quell, JM
    Sefton, J
    Lue, JC
    Gibson, JR
    Chandraratna, RAS
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (05) : 705 - 711
  • [5] A COMPARISON OF THE OCULAR HYPOTENSIVE EFFICACY OF ONCE-DAILY AND TWICE-DAILY LEVOBUNOLOL TREATMENT
    RAKOFSKY, SI
    MELAMED, S
    COHEN, JS
    SLIGHT, JR
    SPAETH, G
    LEWIS, RA
    ZBROWSKIGUTMAN, L
    ETO, CY
    LUE, JC
    NOVACK, GD
    OPHTHALMOLOGY, 1989, 96 (01) : 8 - 11
  • [6] EFFICACY AND SAFETY OF CEFIXIME ONCE-DAILY COMPARED TO TWICE-DAILY IN OTITIS-MEDIA, URTI AND LRTI IN CHILDREN
    HELWIG, H
    LUCHTRATH, M
    HOSTALEK, U
    JOURNAL OF DRUG DEVELOPMENT, 1993, 6 : 27 - 29
  • [7] COMPARISON OF THE EFFICACY AND SAFETY OF ONCE-DAILY VERSUS TWICE-DAILY FORMULATIONS OF DILTIAZEM IN THE TREATMENT OF SYSTEMIC HYPERTENSION
    RUDDY, TD
    WRIGHT, JM
    SAVARD, D
    HANDA, SP
    CHOCKALINGAM, A
    BOULET, AP
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (03) : 413 - 420
  • [8] Efficacy and safety of once-daily and twice-daily clarithromycin formulations in the treatment of acute exacerbations of chronic bronchitis
    Vetter, N
    Argryopoulou-Pataka, P
    Droszcz, W
    Estruch-Riba, R
    Thomas, P
    MacLeod, CM
    ADVANCES IN THERAPY, 1999, 16 (01) : 13 - 21
  • [9] LITHIUM TREATMENT - A COMPARISON OF ONCE-DAILY AND TWICE-DAILY DOSING
    ABRAHAM, G
    DELVA, N
    WALDRON, J
    LAWSON, JS
    OWEN, J
    ACTA PSYCHIATRICA SCANDINAVICA, 1992, 85 (01) : 65 - 69
  • [10] Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin - A noninferiority trial
    Clegg, Herbert W.
    Ryan, Amy G.
    Dallas, Steven D.
    Kaplan, Edward L.
    Johnson, Dwight R.
    Norton, H. James
    Roddey, Oliver F.
    Martin, Edward S.
    Swetenburg, Raymond L.
    Koonce, Elizabeth W.
    Felkner, Mary M.
    Giftos, P. Michael
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (09) : 761 - 767